Exclusive interview with JSC Farmak CEO Augustin Dubnicka for the Interfax-Ukraine News Agency
Filya Zhebrovska , the CEO of Ukraine's leading pharmaceuticals producer Farmak, speaks to the Kyiv Post in her Kyiv office on June 6. Zhebrovska thinks the newly introduced compensation program for prescription drugs is a move in the right direction.
Since Ukraine gained independence, the country’s pharmaceutical industry has seen significant changes in drugs manufacturing regulations, as well as rules on efficacy and safety evaluations. In the early nineties, these standards were duplications of old Soviet requirements, but starting from 2002 the first step in harmonizing them with EU regulations was taken, through the adoption of Good Manufacturing Practice (GMP) principles at the national level.